Home › Resources › Safety Guidelines

Safety Guidelines

Evidence-based safety protocols for research peptide handling, reconstitution, storage, and administration — developed for research and educational contexts.

⚠️
Important: This information is for educational and research purposes only. It does not constitute medical advice. Research peptides are not approved for human therapeutic use in most jurisdictions. Always consult a qualified healthcare professional.

01 Storage Guidelines

❄️ Lyophilised (Powder) Peptides

  • Store at –20°C (freezer) for long-term storage (up to 24 months)
  • Can be kept at 2–8°C (refrigerator) for up to 3 months
  • Avoid repeated freeze-thaw cycles
  • Protect from light, moisture, and heat
  • Keep sealed until ready to reconstitute

🧪 Reconstituted Peptides

  • Store at 2–8°C (refrigerator) after reconstitution
  • Use within 4–6 weeks of reconstitution
  • Never freeze reconstituted peptide solutions
  • Use bacteriostatic water (BW) to extend shelf life vs sterile water
  • Label with reconstitution date and concentration

02 Reconstitution Protocol

  1. Gather materials: Lyophilised peptide vial, bacteriostatic water, alcohol swabs, appropriate syringe
  2. Clean surfaces: Wipe vial tops with 70% isopropyl alcohol swabs and allow to dry
  3. Calculate volume: Use our Reconstitution Calculator to determine the exact BW volume needed for your desired concentration
  4. Add BW slowly: Insert needle at the side of the rubber stopper and let BW run down the glass wall — do not spray directly onto the powder cake
  5. Mix gently: Swirl slowly, do not shake. Vigorous agitation can degrade peptide bonds
  6. Verify clarity: Solution should be clear and colourless (some peptides may have a slight tint)
  7. Label and store: Record the date, concentration, and peptide name on the vial

03 General Contraindications

❌ Do Not Use If:

  • Active cancer or history of hormone-sensitive cancers (GH secretagogues)
  • Known hypersensitivity to the peptide or any excipient
  • Pregnancy or breastfeeding (insufficient safety data)
  • Active autoimmune conditions (immune-modulating peptides)
  • Severe renal or hepatic impairment (dose adjustment required)
  • Children and adolescents (no paediatric safety data)

⚠️ Use With Caution If:

  • Taking anticoagulant medications (BPC-157, TB-500)
  • Diabetes or insulin resistance (GH secretagogues)
  • Hypothyroidism or thyroid conditions
  • History of psychiatric conditions (cognitive peptides)
  • Concurrent use of corticosteroids
  • Recent surgery or active infection

04 Adverse Event Recognition

Common (Mild)

  • Injection site reactions (redness, swelling, bruising)
  • Transient nausea (GLP-1 agonists, GHRPs)
  • Water retention or mild oedema (GH peptides)
  • Flushing or warmth at injection site
  • Temporary fatigue or headache

Seek Medical Attention If:

  • Anaphylaxis or severe allergic reaction (hives, difficulty breathing)
  • Severe injection site infection (increased warmth, pus, spreading redness)
  • Significant cardiovascular effects (palpitations, chest pain)
  • Severe GI symptoms (vomiting, acute abdominal pain)
  • Neurological symptoms (seizure, severe headache)

05 Injection Safety

  1. Sterile technique: Always use new, sterile insulin syringes. Never reuse needles
  2. Site rotation: Rotate injection sites to prevent lipodystrophy and reduce local reactions
  3. Subcutaneous technique: Most research peptides are administered subcutaneously (SC). Pinch skin, insert needle at 45–90°, inject slowly
  4. Intranasal peptides: Semax, Selank, and some other peptides can be administered intranasally — use appropriate nasal spray devices
  5. Sharps disposal: Use a proper sharps container. Never dispose of needles in regular waste